GNTANASDAQGenenta Science SpA ADR

GNTA price activity

Last Price

Change (24hr)

USD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

GNTA price performance

-23,64%

-15,44%

YTD

-65,67%

GNTA price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

US-NASDAQ rank

N/A

Sector Rank

N/A

GNTA details

View company profile

View company website

View US-NASDAQ Official Page

Dividendos de GNTA

Ver mais

quote.marketSignals

Mais formas de descobrir

Ver notícias de United States Descubra sinais de NASDAQ Ver todas as ações de NASDAQ Ver todos os ETFs de NASDAQ

Genenta Science SpA ADR (US-NASDAQ: GNTA)

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Price: $1.26

Sector: Healthcare — Biotechnology